JP Morgan Chase
IRWD icon

JP Morgan Chase’s Ironwood Pharmaceuticals IRWD Stock Holding History

JP Morgan Chase’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-151,041
Closed -$2.33M – 5797
2018
Q3 		$2.33M Buy
151,041
+59,700
+65% +$944K ﹤0.01% 3348
2018
Q2 		$1.46M Buy
+91,341
New +$1.35M ﹤0.01% 3616
2016
Q3 		– Sell
-74,625
Closed -$817K – 4669
2016
Q2 		$817K Buy
+74,625
New +$729K ﹤0.01% 3252

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase's IRWD Position: Q2 2026 in Review

JP Morgan Chase increased its Ironwood Pharmaceuticals (IRWD) stake by 80% in Q2 2026, buying an estimated $364K and bringing the position to 212,575 shares worth $914K. The position accounts for ﹤0.01% of the portfolio, ranked #4733.

JP Morgan Chase first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.6M in Q4 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • JP Morgan Chase held 212,575 shares of Ironwood Pharmaceuticals worth $914K as of Q2 2026.
  • JP Morgan Chase bought 94,384 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $364K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4733 holding.
  • JP Morgan Chase first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Ironwood Pharmaceuticals position peaked at $24.6M in Q4 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.